Please login to the form below

Not currently logged in
Email:
Password:

Dr Irina Antonijevic joins vasopharm

Becomes chief medical officer of the cerebrovascular specialist

vasopharm Dr Irina AntonijevicWürzburg, Germany-based vasopharm has appointed Dr Irina Antonijevic to the newly-created position of chief medical officer.

In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203.

She brings over 15 years of global drug development experience in neuroscience to vasopharm, having held positions at Schering's German operations and Lundbeck Research in the US.

Most recently, Dr Antonijevic served as global head of early development in neurology, multiple sclerosis and ophthalmology at Sanofi Genzyme in the US.

Dr Andrew Clark, chairman of the board at vasopharm, said: “We are delighted that Dr Antonijevic will be joining the team at vasopharm.

“Not only will we benefit from her clinical capabilities in our ongoing pivotal study of VAS203 in TBI, but also from her extensive expertise in pre-clinical development as we examine the compound in additional indications.

“We see her commitment to vasopharm as a substantial endorsement of the potential of the programmes underway at the company.”

25th November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

Infographics